[{"address1": "One World Trade Center", "address2": "Suite 8500", "city": "New York", "state": "NY", "zip": "10007", "country": "United States", "phone": "212-220-6633", "website": "https://www.mindmed.co", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.", "fullTimeEmployees": 57, "auditRisk": 8, "boardRisk": 4, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 8, "governanceEpochDate": 1717200000, "maxAge": 86400, "priceHint": 2, "previousClose": 7.25, "open": 7.25, "dayLow": 7.07, "dayHigh": 7.44, "regularMarketPreviousClose": 7.25, "regularMarketOpen": 7.25, "regularMarketDayLow": 7.07, "regularMarketDayHigh": 7.44, "beta": 2.43, "forwardPE": -4.874172, "volume": 4116027, "regularMarketVolume": 4116027, "averageVolume": 1540288, "averageVolume10days": 1367810, "averageDailyVolume10Day": 1367810, "bid": 7.34, "ask": 7.38, "bidSize": 300, "askSize": 100, "marketCap": 528980864, "fiftyTwoWeekLow": 2.41, "fiftyTwoWeekHigh": 12.22, "fiftyDayAverage": 8.6003, "twoHundredDayAverage": 5.60955, "currency": "USD", "enterpriseValue": 290839040, "floatShares": 57783271, "sharesOutstanding": 71872400, "sharesShort": 6133922, "sharesShortPriorMonth": 6924134, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0853, "heldPercentInsiders": 0.026700001, "heldPercentInstitutions": 0.49151, "shortRatio": 5.27, "shortPercentOfFloat": 0.0854, "impliedSharesOutstanding": 71872400, "bookValue": 2.755, "priceToBook": 2.6715064, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -125317000, "trailingEps": -2.93, "forwardEps": -1.51, "lastSplitFactor": "1:15", "lastSplitDate": 1661731200, "52WeekChange": 1.2439024, "SandP52WeekChange": 0.26238096, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "MNMD", "underlyingSymbol": "MNMD", "shortName": "Mind Medicine (MindMed) Inc.", "longName": "Mind Medicine (MindMed) Inc.", "firstTradeDateEpochUtc": 1479220200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "82effaa6-cea3-362e-b9a1-33a692529ba0", "messageBoardId": "finmb_631045282", "gmtOffSetMilliseconds": -14400000, "currentPrice": 7.36, "targetHighPrice": 36.0, "targetLowPrice": 16.0, "targetMeanPrice": 24.25, "targetMedianPrice": 21.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 252332000, "totalCashPerShare": 3.511, "totalDebt": 14190000, "quickRatio": 3.866, "currentRatio": 3.914, "debtToEquity": 7.238, "returnOnAssets": -0.27609, "returnOnEquity": -0.76787, "freeCashflow": 493250, "operatingCashflow": -67632000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]